{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:25Z","timestamp":1786985005789,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["2-11\/1-2012-0001"],"award-info":[{"award-number":["2-11\/1-2012-0001"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbi.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:41:14Z","timestamp":1473766874000},"page":"219-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice"],"prefix":"10.1016","volume":"59","author":[{"given":"\u00c9va","family":"Borb\u00e9ly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Hajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Scheich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"T\u00e9kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00f3f","family":"L\u00e1szl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Ollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Kormos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Gaszner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kar\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"L\u00e9n\u00e1rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Paige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Szolcs\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pint\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Keeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Helyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.09.004_b0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2710.1999.00257.x","article-title":"Substance P antagonists: the next breakthrough in treating depression?","volume":"24","author":"Baby","year":"1999","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bbi.2016.09.004_b0010","first-page":"25","article-title":"Acute treatment with antidepressant drugs selectively increases the expression of c-Fos in the rat brain","volume":"20","author":"Beck","year":"1995","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2016.09.004_b0015","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood-2010-06-291062","article-title":"Targeted deletion of the tachykinin 4 gene (TAC4-\/-) influences the early stages of B lymphocyte development","volume":"116","author":"Berger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2016.09.004_b0020","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1523\/JNEUROSCI.22-22-10046.2002","article-title":"Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene","volume":"22","author":"Bilkei-Gorzo","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2016.09.004_b0025","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0006-3223(02)01544-5","article-title":"Substance P serum levels are increased in major depression: preliminary results","volume":"53","author":"Bondy","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.004_b0030","doi-asserted-by":"crossref","first-page":"e61684","DOI":"10.1371\/journal.pone.0061684","article-title":"Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouse","volume":"8","author":"Borb\u00e9ly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2016.09.004_b0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.npep.2013.10.012","article-title":"Neuropeptides in learning and memory","volume":"47","author":"Borb\u00e9ly","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbi.2016.09.004_b0040","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12403","article-title":"Neuroendocrine regulation of anxiety: beyond the hypothalamic-pituitary-adrenal axis","volume":"28","author":"Borrow","year":"2016","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2016.09.004_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138955713804484758","article-title":"Non-monoaminergic targets for the development of antidepressants: focus on neuropeptides","volume":"13","author":"Catena-Dell\u2019Osso","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbi.2016.09.004_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4196\/kjpp.2013.17.4.321","article-title":"Changes in c-Fos expression in the forced swimming test: common and distinct modulation in rat brain by desipramine and citalopram","volume":"17","author":"Choi","year":"2013","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbi.2016.09.004_b0055","first-page":"81","article-title":"The hypocretin\/orexin system in sleep disorders: preclinical insights and clinical progress","volume":"8","author":"Chow","year":"2016","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.bbi.2016.09.004_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2016.09.004_b0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.bbi.2016.09.004_b0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2016.09.004_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/jpet.111.186155","article-title":"Hemokinin-1 stimulates prostaglandin E\u2082 production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase","volume":"340","author":"Dai","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.09.004_b0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0196-9781(99)00154-0","article-title":"Anxiogenic effects of substance P and its 7\u201311 C terminal, but not the 1\u20137 N terminal, injected into the dorsal periaqueductal gray","volume":"20","author":"De Ara\u00fajo","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.bbi.2016.09.004_b0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/32904","article-title":"Altered nociception, analgesia and aggression in mice lacking the receptor for substance P","volume":"392","author":"De Felipe","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2016.09.004_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bbi.2016.09.004_b0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbr.2004.03.020","article-title":"Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats","volume":"154","author":"Duarte","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0028-3908(03)00150-3","article-title":"Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils","volume":"45","author":"Duffy","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0105","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1073\/pnas.0400794101","article-title":"Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats","volume":"101","author":"Ebner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.09.004_b0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","article-title":"The role of substance P in stress and anxiety responses","volume":"31","author":"Ebner","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbi.2016.09.004_b0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2005.09.005","article-title":"Effect of intrathecal administration of hemokinin-1 on the withdrawal response to noxious thermal stimulation of the rat hind paw","volume":"392","author":"Endo","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2016.09.004_b0120","doi-asserted-by":"crossref","first-page":"e00223","DOI":"10.1002\/prp2.223","article-title":"Preclinical animal anxiety research \u2013 flaws and prejudices","volume":"4","author":"Ennaceur","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbi.2016.09.004_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0006-8993(91)90378-9","article-title":"Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro","volume":"538","author":"Faria","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0130","article-title":"The neurobiology of depression: an integrated overview from biological theories to clinical evidence","author":"Ferrari","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2016.09.004_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2005.07.020","article-title":"Effects and mechanisms of supraspinal administration of rat\/mouse hemokinin-1, a mammalian tachykinin peptide, on nociception in mice","volume":"1056","author":"Fu","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroscience.2014.07.001","article-title":"Hemokinin-1 mediates pruriceptive processing in the rat spinal cord","volume":"277","author":"Funahashi","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2016.09.004_b0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.11.046","volume":"202","author":"Gaszner","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2016.09.004_b0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0155","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(24)39091-3","article-title":"Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain","volume":"294","author":"Gonzalez","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.09.004_b0160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.bp.107.037879","article-title":"Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations","volume":"191","author":"Hafizi","year":"2007","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.bbi.2016.09.004_b0165","first-page":"84","article-title":"Distribution of substance P in brain and periphery and its possible role as a cotransmitter","volume":"91","author":"H\u00f6kfelt","year":"1982","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.bbi.2016.09.004_b0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0001-6918(68)90020-6","article-title":"A note on a new technique of recording ambulation in the open field test and its validation","volume":"28","author":"Holland","year":"1968","journal-title":"Acta Psychol. (Amst.)"},{"key":"10.1016\/j.bbi.2016.09.004_b0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10253890009001125","article-title":"Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors","volume":"3","author":"Jessop","year":"2000","journal-title":"Stress"},{"key":"10.1016\/j.bbi.2016.09.004_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.brainres.2012.01.056","article-title":"Partial reduction in neural cell adhesion molecule (NCAM) in heterozygous mice induces depression-related behaviour without cognitive impairment","volume":"1447","author":"J\u00fcrgenson","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbi.2016.09.004_b0190","first-page":"6","article-title":"Experimental study of the effects of citalopram, olanzapine, and their combinations in tests for antipsychotic, antidepressant and anxiolytic activities of drugs","volume":"71","author":"Kozlovski\u012d","year":"2008","journal-title":"Eksp Klin Farmakol"},{"key":"10.1016\/j.bbi.2016.09.004_b0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbr.2009.12.022","article-title":"The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala","volume":"208","author":"L\u00e1szl\u00f3","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-2004-832599","article-title":"Serum levels of substance P and response to antidepressant pharmacotherapy","volume":"37","author":"Lieb","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbi.2016.09.004_b0205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02431541","article-title":"Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test","volume":"96","author":"Malinge","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0215","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/en.2008-1721","article-title":"Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity","volume":"150","author":"McEuen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2016.09.004_b0220","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2009.05331.x","article-title":"Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease","volume":"1186","author":"McEwen","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2016.09.004_b0225","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ni1201-1088","article-title":"Hemokinin 1 is a full agonist at the substance P receptor","volume":"2","author":"Morteau","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2016.09.004_b0230","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Mu\u00f1oz","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbi.2016.09.004_b0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.091","article-title":"Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice","volume":"499","author":"Nielsen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2016.09.004_b0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","article-title":"Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test","volume":"192","author":"O\u2019Leary","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0245","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00018-004-4035-x","article-title":"Hemokinins and endokinins","volume":"61","author":"Page","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2016.09.004_b0250","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2003"},{"key":"10.1016\/j.bbi.2016.09.004_b0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0166-4328(86)90090-2","article-title":"The effect of substance P and its fragments on passive avoidance retention and brain monoamine activity","volume":"21","author":"Pelleymounter","year":"1986","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2016.09.004_b0260","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11055-010-9286-4","article-title":"Immobility and hyperthermia in the tail suspension test: association with the Porsolt test and the reflex startle reaction in 11 inbred mouse strains and the effects of genetic knockout of MAO A","volume":"40","author":"Popova","year":"2010","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.bbi.2016.09.004_b0265","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-6997(25)06810-3","article-title":"Receptors and antagonists for substance P and related peptides","volume":"46","author":"Regoli","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2016.09.004_b0270","first-page":"257","article-title":"Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists","volume":"3","author":"Rupniak","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbi.2016.09.004_b0275","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008877-200111000-00011","article-title":"Comparison of the phenotype of NK1R-\/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs","volume":"12","author":"Rupniak","year":"2001","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbi.2016.09.004_b0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2015.09.021","article-title":"Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models","volume":"101","author":"Scheich","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0285","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(25)12676-1","article-title":"Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists","volume":"255","author":"Shibata","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.09.004_b0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10571-011-9775-1","article-title":"Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced Fos expression in overlapping brain regions","volume":"32","author":"Silva","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2016.09.004_b0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(96)00390-1","article-title":"Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice","volume":"311","author":"Teixeira","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2016.09.004_b0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1515\/REVNEURO.1994.5.4.309","article-title":"The action of ANP, BNP and related peptides on motivated behavior in rats","volume":"5","author":"Telegdy","year":"1994","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbi.2016.09.004_b0305","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pnpbp.2007.08.001","article-title":"Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram","volume":"32","author":"T\u00f5nissaar","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.004_b0310","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.115.230060","article-title":"Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells","volume":"356","author":"Tsilioni","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.09.004_b0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00008877-200302000-00009","article-title":"The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test","volume":"14","author":"Varty","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbi.2016.09.004_b0320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00213-003-1545-4","article-title":"Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors","volume":"170","author":"Vendruscolo","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.004_b0325","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.peptides.2010.04.025","article-title":"Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice","volume":"31","author":"Watanabe","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.bbi.2016.09.004_b0330","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2016.09.004_b0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2016.06.059","article-title":"Effect of acute imipramine administration on the pattern of forced swim-induced c-Fos expression in the mouse brain","volume":"629","author":"Yanagida","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2016.09.004_b0340","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/80826","article-title":"Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis","volume":"1","author":"Zhang","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2016.09.004_b0345","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1073\/pnas.95.5.2630","article-title":"Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene","volume":"95","author":"Zimmer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2016.09.004_b0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(03)00305-7","article-title":"Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse","volume":"345","author":"Zocchi","year":"2003","journal-title":"Neurosci. Lett."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116304135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116304135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:25:31Z","timestamp":1740414331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159116304135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":70,"alternative-id":["S0889159116304135"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.09.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}